- Home
- SGHT
SGHT
Sight Sciences Inc.
as of 01-14-2026 3:32pm EST
$6.90
+$0.07
+1.02%
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | MENLO PARK |
| Market Cap: | 395.5M | IPO Year: | 2021 |
| Target Price: | $8.23 | AVG Volume (30 days): | 342.5K |
| Analyst Decision: | Buy | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.89 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.03 - $9.24 | Next Earning Date: | 03-04-2026 |
| Revenue: | $76,052,000 | Revenue Growth: | -4.39% |
| Revenue Growth (this year): | -1.48% | Revenue Growth (next year): | 12.07% |
AI-Powered SGHT Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 75.66%
75.66%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Sight Sciences Inc. (SGHT)
HAYDEN JEREMY B.
Sell
Chief Legal Officer
SGHT Jan 6, 2026
Avg Cost/Share
$7.48
Shares
1,785
Total Value
$13,351.80
Owned After
245,420
SEC Form 4
Badawi David
Sell
Chief Technology Officer
SGHT Jan 6, 2026
Avg Cost/Share
$7.48
Shares
3,695
Total Value
$27,638.60
Owned After
1,917,109
SEC Form 4
Bauerlein Alison
Sell
Chief Operating Officer
SGHT Jan 6, 2026
Avg Cost/Share
$7.48
Shares
9,647
Total Value
$72,159.56
Owned After
599,983
SEC Form 4
Badawi Paul
Sell
President and CEO
SGHT Jan 6, 2026
Avg Cost/Share
$7.48
Shares
11,870
Total Value
$88,787.60
Owned After
5,925,276
SEC Form 4
Taylor Brenton
Sell
EVP, Operations & R&D
SGHT Jan 6, 2026
Avg Cost/Share
$7.48
Shares
619
Total Value
$4,630.12
Owned After
170,212
SEC Form 4
Rodberg James
Sell
Chief Financial Officer
SGHT Jan 6, 2026
Avg Cost/Share
$7.48
Shares
594
Total Value
$4,443.12
Owned After
153,846
SEC Form 4
HAYDEN JEREMY B.
Sell
Chief Legal Officer
SGHT Jan 5, 2026
Avg Cost/Share
$7.82
Shares
9,385
Total Value
$73,390.70
Owned After
245,420
SEC Form 4
Badawi David
Sell
Chief Technology Officer
SGHT Jan 5, 2026
Avg Cost/Share
$7.82
Shares
3,051
Total Value
$23,858.82
Owned After
1,917,109
SEC Form 4
Bauerlein Alison
Sell
Chief Operating Officer
SGHT Jan 5, 2026
Avg Cost/Share
$7.82
Shares
10,896
Total Value
$85,206.72
Owned After
599,983
SEC Form 4
Rodberg James
Sell
Chief Financial Officer
SGHT Jan 5, 2026
Avg Cost/Share
$7.82
Shares
4,405
Total Value
$34,447.10
Owned After
153,846
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| HAYDEN JEREMY B. | SGHT | Chief Legal Officer | Jan 6, 2026 | Sell | $7.48 | 1,785 | $13,351.80 | 245,420 | |
| Badawi David | SGHT | Chief Technology Officer | Jan 6, 2026 | Sell | $7.48 | 3,695 | $27,638.60 | 1,917,109 | |
| Bauerlein Alison | SGHT | Chief Operating Officer | Jan 6, 2026 | Sell | $7.48 | 9,647 | $72,159.56 | 599,983 | |
| Badawi Paul | SGHT | President and CEO | Jan 6, 2026 | Sell | $7.48 | 11,870 | $88,787.60 | 5,925,276 | |
| Taylor Brenton | SGHT | EVP, Operations & R&D | Jan 6, 2026 | Sell | $7.48 | 619 | $4,630.12 | 170,212 | |
| Rodberg James | SGHT | Chief Financial Officer | Jan 6, 2026 | Sell | $7.48 | 594 | $4,443.12 | 153,846 | |
| HAYDEN JEREMY B. | SGHT | Chief Legal Officer | Jan 5, 2026 | Sell | $7.82 | 9,385 | $73,390.70 | 245,420 | |
| Badawi David | SGHT | Chief Technology Officer | Jan 5, 2026 | Sell | $7.82 | 3,051 | $23,858.82 | 1,917,109 | |
| Bauerlein Alison | SGHT | Chief Operating Officer | Jan 5, 2026 | Sell | $7.82 | 10,896 | $85,206.72 | 599,983 | |
| Rodberg James | SGHT | Chief Financial Officer | Jan 5, 2026 | Sell | $7.82 | 4,405 | $34,447.10 | 153,846 |
Latest Sight Sciences Inc. News
SGHT Breaking Stock News: Dive into SGHT Ticker-Specific Updates for Smart Investing
GlobeNewswire
Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Highlights
📊
AI Sentiment
Positive
7/10
Simply Wall St.
Looking At The Narrative For Sight Sciences SGHT After Medicare Coverage Shifts
📊
AI Sentiment
Positive
7/10
Simply Wall St.
Sight Sciences, Inc.'s (NASDAQ:SGHT) largest shareholders are individual investors with 30% ownership, institutions own 25%
➖
AI Sentiment
Neutral
5/10
Compare SGHT vs Leading Stocks
See how SGHT stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "SGHT Sight Sciences Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.